Projected Income Statement: BioNTech SE

Forecast Balance Sheet: BioNTech SE

Forecast Balance Sheet - BioNTech SE
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -1,391 -13,663 -11,445 -9,508 -7,141 -11,419 -10,061 -9,487
Change - -882.24% 16.23% 16.92% 24.89% -59.92% 11.89% 5.71%
Announcement Date 3/30/22 3/27/23 3/20/24 3/10/25 3/10/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: BioNTech SE

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 127.5 329.2 249.4 286.5 175.1 204.4 197.4 208.5
Change - 158.2% -24.24% 14.88% -38.88% 16.71% -3.38% 5.59%
Free Cash Flow (FCF) 1 735.7 13,214 4,667 -244.6 280.9 -1,233 -1,583 -1,460
Change - 1,696.13% -64.68% -105.24% 214.84% -539.03% -28.33% 7.74%
Announcement Date 3/30/22 3/27/23 3/20/24 3/10/25 3/10/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: BioNTech SE

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 80.94% 73.75% 22.88% -36.94% -35.61% -73.01% -77.82% -50.39%
EBIT Margin (%) 80.54% 73.03% 18.08% -47.77% -48.95% -101.02% -87.07% -54.48%
EBT Margin (%) 79.29% 74.83% 31.06% -24.63% -36.61% -85.55% -67.07% -36.57%
Net margin (%) 54.24% 54.5% 24.36% -24.18% -39.59% -82.53% -67.17% -38.89%
FCF margin (%) 3.88% 76.34% 122.19% -8.89% 9.79% -66.51% -85.7% -65.29%
FCF / Net Income (%) 7.15% 140.06% 501.62% 36.77% -24.72% 80.59% 127.58% 167.88%

Profitability

        
ROA 113.42% 48.25% 4.02% -2.88% -5.1% -8.6% -6.87% -8.03%
ROE 155.18% 59.06% 4.62% -3.3% -5.88% -8.33% -7.72% -6.44%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 0.67% 1.9% 6.53% 10.41% 6.1% 11.02% 10.69% 9.32%
CAPEX / EBITDA (%) 0.83% 2.58% 28.54% -28.19% -17.13% -15.1% -13.74% -18.5%
CAPEX / FCF (%) 17.33% 2.49% 5.34% -117.13% 62.34% -16.57% -12.48% -14.28%

Items per share

        
Cash flow per share 1 3.426 55.82 22.59 0.864 1.814 -5.255 -3.957 -8.02
Change - 1,529.49% -59.53% -96.18% 110% -389.65% 24.7% -102.67%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 49.04 82.46 85.16 - 76.49 73.97 67.45 64.03
Change - 68.14% 3.28% - - -3.3% -8.81% -5.07%
EPS 1 39.63 37.77 3.83 -2.77 -4.7 -6.347 -5.138 -3.691
Change - -4.69% -89.86% -172.32% -69.68% -35.03% 19.04% 28.17%
Nbr of stocks (in thousands) 241,521 243,019 237,716 239,740 240,455 247,928 247,928 247,928
Announcement Date 3/30/22 3/27/23 3/20/24 3/10/25 3/10/26 - - -
1EUR
Estimates
2026 *2027 *
P/E -11.6x -14.4x
PBR 1x 1.09x
EV / Sales 3.7x 4.45x
Yield - -

EPS & Dividend

EPS & Dividend - BioNTech SE


Y-o-Y evolution of P/E

Valuation ratios - P/E - BioNTech SE
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - BioNTech SE
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - BioNTech SE
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
73.74EUR
Average target price
102.18EUR
Spread / Average Target
+38.57%
  1. Stock Market
  2. Stocks
  3. BNTX Stock
  4. Financials BioNTech SE
BLACK FRIDAY -Get 40% off all subscriptions
BLACK FRIDAY40% off all subscriptions
Get the offer